Corcept Therapeutics, Inc. (CORT)
63.20
-1.78
(-2.74%)
USD |
NASDAQ |
Nov 20, 15:27
Corcept Therapeutics 30-Day Average Daily Volume : 1.126M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.126M |
| November 18, 2026 | 1.111M |
| November 17, 2026 | 1.108M |
| November 16, 2026 | 1.101M |
| November 13, 2026 | 1.098M |
| November 12, 2026 | 1.093M |
| November 11, 2026 | 1.094M |
| November 10, 2026 | 1.087M |
| November 09, 2026 | 1.075M |
| November 06, 2026 | 1.058M |
| November 05, 2026 | 1.038M |
| November 04, 2026 | 1.020M |
| November 03, 2026 | 974149.9 |
| November 02, 2026 | 950348.4 |
| October 30, 2026 | 942164.1 |
| October 29, 2026 | 1.469M |
| October 28, 2026 | 1.459M |
| October 27, 2026 | 1.446M |
| October 26, 2026 | 1.464M |
| October 23, 2026 | 1.443M |
| October 22, 2026 | 1.382M |
| October 21, 2026 | 1.378M |
| October 20, 2026 | 1.380M |
| October 19, 2026 | 1.396M |
| October 16, 2026 | 1.403M |
| Date | Value |
|---|---|
| October 15, 2026 | 1.395M |
| October 14, 2026 | 1.405M |
| October 13, 2026 | 1.419M |
| October 12, 2026 | 1.422M |
| October 09, 2026 | 1.436M |
| October 08, 2026 | 1.436M |
| October 07, 2026 | 1.453M |
| October 06, 2026 | 1.464M |
| October 05, 2026 | 1.472M |
| October 02, 2026 | 1.460M |
| October 01, 2026 | 1.454M |
| September 30, 2026 | 1.454M |
| September 29, 2026 | 1.450M |
| September 28, 2026 | 1.436M |
| September 25, 2026 | 1.422M |
| September 24, 2026 | 1.420M |
| September 23, 2026 | 1.409M |
| September 22, 2026 | 1.405M |
| September 21, 2026 | 1.420M |
| September 18, 2026 | 1.401M |
| September 17, 2026 | 851812.9 |
| September 16, 2026 | 850586.7 |
| September 15, 2026 | 870499.1 |
| September 14, 2026 | 878165.1 |
| September 11, 2026 | 898516.5 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Pfizer Inc. | 34.09M |
| Phibro Animal Health Corp. | 204477.6 |
| Illumina, Inc. | 2.135M |
| Eli Lilly & Co. | 2.850M |
| Merck & Co., Inc. | 9.760M |